MINI DEBATE 11: Paradoja entre los adelantos tecnológicos y las situaciones de crisis e inequidad en el contexto de epidemias y pandemias
Resumen
Palabras clave
Texto completo:
PDFReferencias
-1- Linari MA, González C, Dieuzeide G, Badia MF, Argerich MI, Echenique M, et al. Calidad de vida y prestaciones en salud en pacientes con diabetes mellitus tipo 2 según región geográfica en Argentina. Revista de la Sociedad Argentina de Diabetes 2019; 53 (3): 87-96.
-2- Fong H, Harris E. OMS. Tecnología, innovación y equidad sanitaria. Boletín de la Organización Mundial de la Salud 2015; 93:438-438A. doi: http://dx.doi.org/10.2471/BLT.15.155952.
-3- Coloma J, Harris E. Sustainable transfer of biotechnology to developing countries: fighting poverty by bringing scientific tools to developing-country partners. Ann N Y Acad Sci. 2008; 1136 (1):358–68. http://dx.doi.org/10.1196/annals.1425.014 pmid: 17954678.
-4- Avilés W, Ortega O, Kuan G, Coloma J, Harris E. Integration of information technologies in clinical studies in Nicaragua. PLoS Med. 2007 Oct; 4(10):1578–83. http://dx.doi.org/10.1371/journal.pmed.0040291 pmid: 17958461.
-5- International Diabetes Federation. IDF Diabetes Atlas, 9th ed. Brussels, Belgium. Atlas de la Diabetes de la FID. 2019.
-6- World Health Organization. Global Report on Diabetes. ISBN. 2016.
-7- Mobasseri M, Shirmohammadi M, Amiri T, Vahed N, Hosseini Fard H, Ghojazadeh M. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect. 2020; 10 (2):98-115. Published 2020 Mar 30
-8- Secretaría de Gobierno de Salud. 4ta Encuesta Nacional de Factores de Riesgo. Informe definitivo. 2019; 262. Available from: http://www.msal.gob.ar/images/stories/bes/graficos/0000001622cnt-2019-10_4ta-encuesta-nacional-factores-riesgo.pdf.
-9- Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range. Diabetes Care. 2019.
-10- Serfling G, Kalscheuer H, Schmid SM, Lehnert H. New technologies in diabetes treatment. Internist. 2019.
-11- Diabetes Technology: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020.
-12- Kubiak T, Priesterroth L, Barnard-Kelly K Psychosocial aspects of diabetes technology Diabet. Med. (2020) 37, 448–454.
-13- Fagherazzi G, Ravaud P. Digital diabetes: Perspectives for diabetes prevention, management and research Diabetes & Metabolism 45 (2019) 322–329.
-14- Borges U. Continuous Glucose Monitoring in Type 1 Diabetes Human Factors and Usage Journal of Diabetes Science and Technology 2016, Vol. 10(3) 633–639.
-15- Heinemann L. Elderly patients with diabetes: special aspets to consider. J Diabetes sci Technol 2019, vol 13(4)611-613.
-16- Diabetes Technology: Standardas of Medical Care in Diabetes. 2020. Diabetes Care 2020; 43: (Suppl1): S77-S88.
-17- Mulinacci G, Alonso T, Snell-Bergeon J K, ShahV N. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes. Diabetes Technol Ther 2019; 21: 6-10.
-18- Zhu J, Volkening L K, Laffel L. Distinct Patterns of Daily Glucose Variability by Pubertal Status in Youth With Type 1 Diabetes. Diabetes Care 2020; 43: 22-28.
-19- Dovc K. Cargnelutti K, Sturm A, Selb J, Bratina N. Continuous Glucose Monitoring Use and Glucose Variability in Pre-school Children with Type 1 Diabetes, Diabetes Res Clin Pract 2019; 147: 76-80.
-20- Piona C, Dovc K, Mutlu G Y, Grad K, Gregorc P, Battelino T, Bratina N. Nonadjunctive flash glucose monitoring system use during summer-camp in children with type 1 diabetes – the free-summer study. Pediatr Diabetes 2018; 19: 1285-1293
-21- Suzuki J, Urakami T, Yoshida K, Kuwabara R, Mine Y, Aoki M, Morioka I. Association between scanning frequency of flash glucose monitoring and continuous glucose monitoring-derived glycemic makers in children and adolescents with type 1 diabetes. Pediatr Int. 2020 Aug 3. doi: 10.1111/ped.14412.
-22- Tauschmann M, Allen J M, Nagl K y coll. HomeUse of Day and Night Hybrid Closed Loop Insulin Delivery in Very Young Children: A Multicenter 3- Week, Randomized Trial. Diabetes Care 2019; 42: 594-600.
DOI: http://dx.doi.org/10.47196/diab.v54i3Sup.320
Copyright (c) 2020 Sociedad Argentina de Diabetes Asociación Civil